Non-small cell lung cancer: whole-body MR examination for M-stage assessment--utility for whole-body diffusion-weighted imaging compared with integrated FDG PET/CT.
暂无分享,去创建一个
S. Matsumoto | Y. Ohno | D. Takenaka | K. Sugimura | M. Nogami | T. Yoshikawa | H. Koyama | Y. Onishi | Y. Kotani
[1] I. Narabayashi,et al. 2-[Fluorine-18]-fluoro-2-deoxy-d-glucose positron emission tomography/computed tomography versus whole-body diffusion-weighted MRI for detection of malignant lesions: initial experience , 2007, Annals of nuclear medicine.
[2] J. Debatin,et al. Whole-body MR imaging in 30 seconds with real-time true FISP and a continuously rolling table platform: feasibility study. , 2001, Radiology.
[3] R C Young,et al. Combination versus single agent chemotherapy: A review of the basis for selection of drug treatment of cancer , 1975, Cancer.
[4] Michael T. Halpern,et al. EVALUATION OF HEALTHCARE RESOURCE UTILIZATION (HRU) AND COSTS OF ANEMIA AMONG CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) PATIENTS , 2005 .
[5] Susumu Mori,et al. Diffusion-tensor MR imaging and fiber tractography: a new method of describing aberrant fiber connections in developmental CNS anomalies. , 2005, Radiographics : a review publication of the Radiological Society of North America, Inc.
[6] N. deSouza,et al. Diffusion-weighted magnetic resonance imaging and its application to cancer , 2006, Cancer imaging : the official publication of the International Cancer Imaging Society.
[7] K. Mori,et al. Detection of brain metastasis in potentially operable non-small cell lung cancer: a comparison of CT and MRI. , 1999, Chest.
[8] Werner Hacke,et al. Imaging-Based Decision Making in Thrombolytic Therapy for Ischemic Stroke: Present Status , 2003, Stroke.
[9] H. Svanholm,et al. Reproducibility of histomorphologic diagnoses with special reference to the kappa statistic , 1989, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.
[10] A. A. Abdel Razek,et al. Role of diffusion-weighted MR imaging in cervical lymphadenopathy , 2006, European Radiology.
[11] M. Matoba,et al. Lung carcinoma: diffusion-weighted mr imaging--preliminary evaluation with apparent diffusion coefficient. , 2007, Radiology.
[12] R. Kerbel,et al. Consequences of angiogenesis for tumor progression, metastasis and cancer therapy. , 1995, Anti-cancer drugs.
[13] C. Claussen,et al. Tumor Detection by Diffusion-Weighted MRI and ADC-Mapping—Initial Clinical Experiences in Comparison to PET-CT , 2007, Investigative radiology.
[14] J. Debatin,et al. Whole-body MR imaging: evaluation of patients for metastases. , 2004, Radiology.
[15] L. Tanoue,et al. The noninvasive staging of non-small cell lung cancer: the guidelines. , 2003, Chest.
[16] D. Figarella-Branger,et al. Fetal brain injury. , 2004, Journal of neuroradiology. Journal de neuroradiologie.
[17] R. Walker,et al. Turbo STIR magnetic resonance imaging as a whole‐body screening tool for metastases in patients with breast carcinoma: Preliminary clinical experience , 2000, Journal of magnetic resonance imaging : JMRI.
[18] T. Turkington,et al. Clinical applications of PET in oncology. , 2004, Radiology.
[19] T. Takahara,et al. Diffusion weighted whole body imaging with background body signal suppression (DWIBS): technical improvement using free breathing, STIR and high resolution 3D display. , 2004, Radiation medicine.
[20] Y. Ohno,et al. Whole‐body MR imaging vs. FDG‐PET: Comparison of accuracy of M‐stage diagnosis for lung cancer patients , 2007, Journal of magnetic resonance imaging : JMRI.
[21] V. Narra,et al. Whole-body fast inversion recovery MR imaging of small cell neoplasms in pediatric patients: a pilot study. , 2002, AJR. American journal of roentgenology.
[22] J. Deslauriers. Current surgical treatment of nonsmall cell lung cancer 2001 , 2002, European Respiratory Journal.
[23] R. Govindan,et al. Recent advances and future perspectives in the management of lung cancer. , 2005, Current problems in surgery.
[24] H. Shinmoto,et al. Prostate cancer screening: The clinical value of diffusion‐weighted imaging and dynamic MR imaging in combination with T2‐weighted imaging , 2007, Journal of magnetic resonance imaging : JMRI.
[25] Heiko Schöder,et al. Deep-Inspiration Breath-Hold PET/CT: Clinical Findings with a New Technique for Detection and Characterization of Thoracic Lesions , 2007, Journal of Nuclear Medicine.
[26] R. Coleman,et al. Screening for cerebral metastases with FDG PET in patients undergoing whole-body staging of non-central nervous system malignancy. , 2003, Radiology.
[27] Alfred A Bartolucci,et al. The accuracy of integrated PET-CT compared with dedicated PET alone for the staging of patients with nonsmall cell lung cancer. , 2004, The Annals of thoracic surgery.
[28] Adolf Pfefferbaum,et al. Using Magnetic Resonance Imaging and Diffusion Tensor Imaging to Assess Brain Damage in Alcoholics , 2003, Alcohol research & health : the journal of the National Institute on Alcohol Abuse and Alcoholism.
[29] O. Schober,et al. Whole-body MR imaging for detection of bone metastases in children and young adults: comparison with skeletal scintigraphy and FDG PET. , 2001, AJR. American journal of roentgenology.
[30] J. Ferlay,et al. Global Cancer Statistics, 2002 , 2005, CA: a cancer journal for clinicians.
[31] N. Obuchowski,et al. Adrenal mass evaluation in patients with lung carcinoma: a cost-effectiveness analysis. , 2000, AJR. American journal of roentgenology.
[32] Abass Alavi,et al. Whole-body FDG-PET imaging in the management of patients with cancer. , 2002, Seminars in nuclear medicine.
[33] A M Aisen,et al. Characterization of adrenal masses with chemical shift and gadolinium-enhanced MR imaging. , 1995, Radiology.
[34] S. Nawano,et al. Hepatic metastases: diffusion-weighted sensitivity-encoding versus SPIO-enhanced MR imaging. , 2006, Radiology.
[35] U. Tateishi,et al. Bone and soft-tissue sarcoma: preoperative staging with fluorine 18 fluorodeoxyglucose PET/CT and conventional imaging. , 2007, Radiology.
[36] E. O. Bregman,et al. The Present Status. , 1926 .
[37] G. V. von Schulthess,et al. Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography. , 2003, The New England journal of medicine.
[38] H. Gerth,et al. Significant Benefit of Multimodal Imaging: PET/CT Compared with PET Alone in Staging and Follow-up of Patients with Ewing Tumors , 2007, Journal of Nuclear Medicine.
[39] M. J. Fusselman,et al. Brain metastases from non-central nervous system tumors: evaluation with PET. , 1993, Radiology.
[40] Michael E Phelps,et al. Presurgical staging of non-small cell lung cancer: positron emission tomography, integrated positron emission tomography/CT, and software image fusion. , 2005, Chest.
[41] M. Salvatore,et al. 18F-FDG PET/CT, 99mTc-MIBI, and MRI in Evaluation of Patients with Multiple Myeloma , 2008, Journal of Nuclear Medicine.
[42] M. Melamed,et al. Impact of early detection on the clinical course of lung cancer. , 1987, The Surgical clinics of North America.
[43] S. Swensen,et al. Suspected non-small cell lung cancer: incidence of occult brain and skeletal metastases and effectiveness of imaging for detection--pilot study. , 1999, Radiology.
[44] V. Muse,et al. Accuracy of transmission CT and FDG-PET in the detection of small pulmonary nodules with integrated PET/CT , 2006, European Journal of Nuclear Medicine and Molecular Imaging.
[45] L. Liotta,et al. Quantitative relationships of intravascular tumor cells, tumor vessels, and pulmonary metastases following tumor implantation. , 1974, Cancer research.